Why the study?
Obesity causes chronic inflammation leading to metabolic complications, but the specific role of adipose tissue cell death in metabolic inflammation and its impact on energy homeostasis and insulin signalling warrant review.
Key points are not available for this paper at this time.
Design
Literature review
Does not yet warrant changes in obesity management; extends mechanistic understanding but remains hypothesis-generating.
Obesity is a state of low-grade chronic inflammation that causes multiple metabolic diseases. During obesity, signalling via cytokines of the TNF family mediate cell death and inflammation within the adipose tissue, eventually resulting in lipid spill-over, glucotoxicity and insulin resistance. These events ultimately lead to ectopic lipid deposition, glucose intolerance and other metabolic complications with life-threatening consequences. Here we review the literature on how inflammatory responses affect metabolic processes such as energy homeostasis and insulin signalling. This review mainly focuses on the role of cell death in the adipose tissue as a key player in metabolic inflammation.
No takes yet. Share an insight, caveat, or question.
Hildebrandt et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: